The Health Products Regulatory Authority (HPRA) announces that Dr David Muphy has been appointed Director of Veterinary Sciences. Dr Murphy has over 25 years of experience working in the regulation of veterinary medicines, his most recent role being HPRA Veterinary Assessment Manager, with overall responsibility for safety and efficacy assessment of veterinary medicinal products.
From 2016 to 2022, Dr Murphy was Chair of the European Medicines Agency’s (EMA) Committee for Veterinary Medicinal Products (CVMP). As CVMP Chair, he was responsible for guiding the work of the committee and ensuring that its opinions and recommendations were evidence-based, scientifically robust and consistent.
Since 2023, Dr Murphy has acted as Co-Chair of the Veterinary Strategic Focus Group (VSFG). The VSFG is responsible for providing strategic support to the European Heads of Medicines Agencies (HMA) on matters relating to veterinary medicines, with a focus on medicines availability, optimisation of regulatory processes and efficient resource management.
Dr Lorraine Nolan, Chief Executive of the HPRA, welcomed Dr Murphy’s appointment; “Dr Murphy brings a wealth of knowledge and expertise in the evaluation and monitoring of veterinary medicines combined with an in-depth understanding of national and EU regulatory frameworks.”
Dr Murphy holds a PhD from University of Glasgow and a Bachelor of Veterinary Medicine from University College Dublin.
[Dr David Murphy succeeds Dr Gabriel Beechinor who retired on the 4th of September 2025.]
Catch more at IPN HERE
Read IPN September HERE
